Autophagy and cancer therapy

Molecular Pharmacology

Volumn 85, Issue 6, 2014, Pages 830-838

  Thorburn, Andrew ^a   Thamm, Douglas H ^b   Gustafson, Daniel L ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AUTOPHAGY; CANCER GROWTH; CANCER THERAPY; CARCINOGENESIS; CELL ORGANELLE; HUMAN; IONIZING RADIATION; LYSOSOME; MACROAUTOPHAGY; MEMBRANE VESICLE; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

AUTOPHAGY; DISEASE PROGRESSION; HUMANS; NEOPLASMS;

EID: 84899502960     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.091850     Document Type: Review

References (105)

1. Abedin MJ, Wang D, McDonnell MA, Lehmann U, and Kelekar A (2007) Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 14:500-510.
2. Amaravadi RK, Lippincott-Schwartz J, Yin X-M, Weiss WA, Takebe N, Timmer W, Di Paola RS, Lotze MT, and White E (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17:654-666.
3. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, and Thompson CB (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117:326-336.
4. Bareford MD, Hamed HA, Allegood J, Cruickshanks N, Poklepovic A, Park MA, Ogretmen B, Spiegel S, Grant S, and Dent P (2012) Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling. Cancer Biol Ther 13:793-803.
5. Bareford MD, Park MA, Yacoub A, Hamed HA, Tang Y, Cruickshanks N, Eulitt P, Hubbard N, Tye G, and Burow ME et al. (2011) Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer Res 71:4955-4967.
6. Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M, Galavotti S, Young KW, Selmi T, and Yacobi R et al. (2009) Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest 119:1109-1123.
7. Birgisdottir AB, Lamark T, and Johansen T (2013) The LIR motif-crucial for selective autophagy. J Cell Sci 126:3237-3247.
8. Bjørkøy G, Lamark T, Pankiv S, Øvervatn A, Brech A, and Johansen T (2009) Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol 452:181-197.
9. Bristol ML, Emery SM, Maycotte P, Thorburn A, Chakradeo S, and Gewirtz DA (2013) Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? J Pharmacol Exp Ther 344:544-552.
10. Bursch W, Ellinger A, Kienzl H, Török L, Pandey S, Sikorska M, Walker R, and Hermann RS (1996) Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17:1595-1607.
11. Carew JS, Medina EC, Esquivel JA, 2nd, Mahalingam D, Swords R, Kelly K, Zhang H, Huang P, Mita AC, and Mita MM et al. (2010) Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation. J Cell Mol Med 14:2448-2459.
12. Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton JA, Huang P, Giles FJ, and Cleveland JL (2007) Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Ablmediated drug resistance. Blood 110:313-322.
13. Cook KL, Shajahan AN, Wärri A, Jin L, Hilakivi-Clarke LA, and Clarke R (2012) Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen responsiveness. Cancer Res 72:3337-3349.
14. Dimberg LY, and Erson CK, Camidge R, Behbakht K, Thorburn A, and Ford HL (2013) On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics. Oncogene 32:1341-1350.
15. Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, and Deretic V (2011) Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1b. EMBO J 30:4701-4711.
16. Eimer S, Belaud-Rotureau MA, Airiau K, Jeanneteau M, Laharanne E, Vëron N, Vital A, Loiseau H, Merlio JP, and Belloc F (2011) Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death. Cancer Biol Ther 11:1017-1027.
17. Elgendy M, Sheridan C, Brumatti G, and Martin SJ (2011) Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell 42:23-35.
18. Ellerman JE, Brown CK, De Vera M, Zeh HJ, Billiar T, Rubartelli A, and Lotze MT (2007) Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 13:2836-2848.
19. Ganley IG, Wong P-M, Gammoh N, and Jiang X (2011) Distinct autophagosomallysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell 42:731-743.
20. Gonzalez-Malerva L, Park J, Zou L, Hu Y, Moradpour Z, Pearlberg J, Sawyer J, Stevens H, Harlow E, and La Baer J (2011) High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci USA 108:2058-2063.
21. Gump JM, Staskiewicz L, Morgan MJ, Bamberg A, Riches DWH, and Thorburn A (2014) Autophagy variation within a cell population determines cell fate through selective degradation of Fap-1. Nat Cell Biol 16:47-54.
22. Guo JY, Chen H-Y, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JMS, and Karantza V et al. (2011) Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25:460-470.
23. Guo JY, Karsli-Uzunbas G, Mathew R, Aisner SC, Kamphorst JJ, Strohecker AM, Chen G, Price S, Lu W, and Teng X et al. (2013a) Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev 27:1447-1461.
24. Guo XL, Li D, Hu F, Song JR, Zhang SS, Deng WJ, Sun K, Zhao QD, Xie XQ, and Song YJ et al. (2012) Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett 320:171-179.
25. Guo XL, Li D, Sun K, Wang J, Liu Y, Song JR, Zhao QD, Zhang SS, Deng WJ, and Zhao X et al. (2013b) Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma. J Mol Med (Berl) 91:473-483.
26. Hamed HA, Das SK, Sokhi UK, Park MA, Cruickshanks N, Archer K, Ogretmen B, Grant S, Sarkar D, and Fisher PB et al. (2013) Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells. Cancer Biol Ther 14:1039-1049.
27. Hou W, Han J, Lu C, Goldstein LA, and Rabinowich H (2010) Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis. Autophagy 6:891-900.
28. Hou YJ, Dong LW, Tan YX, Yang GZ, Pan YF, Li Z, Tang L, Wang M, Wang Q, and Wang HY (2011) Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma. Lab Invest 91:1146-1157.
29. Hui B, Shi YH, Ding ZB, Zhou J, Gu CY, Peng YF, Yang H, Liu WR, Shi GM, and Fan J (2012) Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma. Cancer 118:5560-5571.
30. Humbert M, Medová M, Aebersold DM, Blaukat A, Bladt F, Fey MF, Zimmer Y, and Tschan MP (2013) Protective autophagy is involved in resistance towards MET inhibitors in human gastric adenocarcinoma cells. Biochem Biophys Res Commun 431:264-269.
31. Ikeda T, Ishii KA, Saito Y, Miura M, Otagiri A, Kawakami Y, Shimano H, Hara H, and Takekoshi K (2013) Inhibition of autophagy enhances sunitinib-induced cytotoxicity in rat pheochromocytoma PC12 cells. J Pharmacol Sci 121:67-73.
32. Kang R, Wang ZH, Wang BQ, Zhang CM, Gao W, Feng Y, Bai T, Zhang HL, Huang-Pu H, and Wen SX (2012) Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells. Am J Otolaryngol 33:678-684.
33. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, and Kondo S (2004) Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11:448-457.
34. Kawaguchi T, Miyazawa K, Moriya S, Ohtomo T, Che XF, Naito M, Itoh M, and Tomoda A (2011) Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress. Int J Oncol 38:643-654.
35. Kimmelman AC (2011) The dynamic nature of autophagy in cancer. Genes Dev 25:1999-2010.
36. Ko A, Kanehisa A, Martins I, Senovilla L, Chargari C, Dugue D, Mariño G, Kepp O, Michaud M, and Perfettini J-L et al. (2014) Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ 21:92-99.
37. Köchl R, Hu XW, Chan EYW, and Tooze SA (2006) Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes. Traffic 7:129-145.
38. Kohli L, Kaza N, Coric T, Byer SJ, Brossier NM, Klocke BJ, Bjornsti M-A, Carroll SL, and Roth KA (2013) 4-Hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res 73:4395-4405.
39. Kon M, Kiffin R, Koga H, Chapochnick J, Macian F, Varticovski L, and Cuervo AM (2011) Chaperone-mediated autophagy is required for tumor growth. Sci Transl Med 3:109ra117.
40. Kroemer G, Mariño G, and Levine B (2010) Autophagy and the integrated stress response. Mol Cell 40:280-293.
41. Ladoire S, Chaba K, Martins I, Sukkurwala AQ, Adjemian S, Michaud M, Poirier-Colame V, and Reiuolo F, Galluzzi L, and White E et al. (2012) Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens. Autophagy 8:1175-1184.
42. Lamoureux F, Thomas C, Crafter C, Kumano M, Zhang F, Davies BR, Gleave ME, and Zoubeidi A (2013) Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363. Clin Cancer Res 19:833-844.
43. Levine B and Klionsky DJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6:463-477.
44. Levy JM and Thorburn A (2011) Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther 131:130-141.
45. Li J, Hou N, Faried A, Tsutsumi S, and Kuwano H (2010) Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur J Cancer 46:1900-1909.
46. Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T, and Kuwano H (2009) Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 16:761-771.
47. Li Y, Hahn T, Garrison K, Cui ZH, Thorburn A, Thorburn J, Hu HM, and Akporiaye ET (2012) The vitamin E analogue a-TEA stimulates tumor autophagy and enhances antigen cross-presentation. Cancer Res 72:3535-3545.
48. Liu D, Yang Y, Liu Q, and Wang J (2011a) Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol 28:105-111.
49. Liu F, Liu D, Yang Y, and Zhao S (2013) Effect of autophagy inhibition on chemotherapy-induced apoptosis in A549 lung cancer cells. Oncol Lett 5:1261-1265.
50. Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu Y, Xie M, Yin X, Livesey KM, and Lotze MT et al. (2011b) HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia 25:23-31.
51. Lock R, Roy S, Kenific CM, Su JS, Salas E, Ronen SM, and Debnath J (2011) Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell 22:165-178.
52. Lorin S, Hamaï A, Mehrpour M, and Codogno P (2013) Autophagy regulation and its role in cancer. Semin Cancer Biol 23:361-379.
53. Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P, Tasdemir E, Pierron G, Troulinaki K, and Tavernarakis N et al. (2007) Functional and physical interaction between Bcl-X (L) and a BH3-like domain in Beclin-1. EMBO J 26:2527-2539.
54. Mancias JD and Kimmelman AC (2011) Targeting autophagy addiction in cancer. Oncotarget 2:1302-1306.
55. Maycotte P, Aryal S, Cummings CT, Thorburn J, Morgan MJ, and Thorburn A (2012) Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 8:200-212.
56. Maycotte P and Thorburn A (2011) Autophagy and cancer therapy. Cancer Biol Ther 11:127-137.
57. McAfee Q, Zhang Z, Samanta A, Levi SM, Ma X-H, Piao S, Lynch JP, Uehara T, Sepulveda AR, and Davis LE et al. (2012) Autophagy inhibitor Lys05 has singleagent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc Natl Acad Sci USA 109:8253-8258.
58. Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, and Mignot G et al. (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334:1573-1577.
59. Mizushima N (2007) Autophagy: process and function. Genes Dev 21:2861-2873.
60. Mizushima N, Yoshimori T, and Ohsumi Y (2011) The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 27:107-132.
61. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, and Hajduk PJ et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435:677-681.
62. Palacios C, Martïn-Përez R, López-Përez AI, Pandiella A, and López-Rivas A (2010) Autophagy inhibition sensitizes multiple myeloma cells to 17-dimethylamino ethylamino-17-demethoxygeldanamycin- induced apoptosis. Leuk Res 34:1533-1538.
63. Pan X, Zhang X, Sun H, Zhang J, Yan M, and Zhang H (2013) Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells. PLoS ONE 8:e56679.
64. Pan Y, Gao Y, Chen L, Gao G, Dong H, Yang Y, Dong B, and Chen X (2011) Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy. Clin Cancer Res 17:3248-3258.
65. Park MA, Zhang G, Martin AP, Hamed H, Mitchell C, Hylemon PB, Graf M, Rahmani M, Ryan K, and Liu X et al. (2008) Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biol Ther 7:1648-1662.
66. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, and Levine B (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122:927-939.
67. Qadir MA, Kwok B, Dragowska WH, To KH, Le D, Bally MB, and Gorski SM (2008) Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat 112:389-403.
68. Rao R, Balusu R, Fiskus W, Mudunuru U, Venkannagari S, Chauhan L, Smith JE, Hembruff SL, Ha K, and Atadja P et al. (2012) Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells. Mol Cancer Ther 11:973-983.
69. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, and Luo S et al. (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90:1383-1435.
70. Rosenfeldt MT, O'Prey J, Morton JP, Nixon C, MacKay G, Mrowinska A, Au A, Rai TS, Zheng L, and Ridgway R et al. (2013) p53 status determines the role of autophagy in pancreatic tumour development. Nature 504:296-300.
71. Rubinsztein DC, Codogno P, and Levine B (2012) Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11:709-730.
72. Rubinsztein DC, Mariño G, and Kroemer G (2011) Autophagy and aging. Cell 146:682-695.
73. Samaddar JS, Gaddy VT, Duplantier J, Thandavan SP, Shah M, Smith MJ, Browning D, Rawson J, Smith SB, and Barrett JT et al. (2008) A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance. Mol Cancer Ther 7:2977-2987.
74. Sasaki K, Tsuno NH, Sunami E, Kawai K, Hongo K, Hiyoshi M, Kaneko M, Murono K, Tada N, and Nirei T et al. (2012) Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study. Anticancer Drugs 23:675-682.
75. Sasaki K, Tsuno NH, Sunami E, Tsurita G, Kawai K, Okaji Y, Nishikawa T, Shuno Y, Hongo K, and Hiyoshi M et al. (2010) Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells. BMC Cancer 10:370.
76. Selvakumaran M, Amaravadi RK, Vasilevskaya IA, and O'Dwyer PJ (2013) Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin Cancer Res 19:2995-3007.
77. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, and Vellard MC et al. (2012) A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 31:1095-1108.
78. Shen J, Zheng H, Ruan J, Fang W, Li A, Tian G, Niu X, Luo S, and Zhao P (2013) Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma. Br J Cancer 109:164-171.
79. Shen S, Kepp O, Michaud M, Martins I, Minoux H, Mëtivier D, Maiuri MC, Kroemer RT, and Kroemer G (2011) Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene 30:4544-4556.
80. Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke AW, Wang XY, Dai Z, Peng YF, and Gu CY et al. (2011) Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 7:1159-1172.
81. Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi T, Hosui A, Ishida H, Tatsumi T, and Kanto T et al. (2012) Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma. Int J Cancer 131:548-557.
82. Shingu T, Fujiwara K, Bogler O, Akiyama Y, Moritake K, Shinojima N, Tamada Y, Yokoyama T, and Kondo S (2009) Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells. Int J Cancer 124:1060-1071.
83. Strohecker AM, Guo JY, Karsli-Uzunbas G, Price SM, Chen GJ, Mathew R, McMahon M, and White E (2013) Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov 3:1272-1285.
84. Sun WL, Chen J, Wang YP, and Zheng H (2011) Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development. Autophagy 7:1035-1044.
85. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, and Tracey KJ et al. (2010a) HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29:5299-5310.
86. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, and Zeh HJ, 3rd et al. (2010b) Endogenous HMGB1 regulates autophagy. J Cell Biol 190:881-892.
87. Tang Y, Hamed HA, Cruickshanks N, Fisher PB, Grant S, and Dent P (2012) Obatoclax and lapatinib interact to induce toxic autophagy through NOXA. Mol Pharmacol 81:527-540.
88. Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, and Kroemer G (2008) Molecular characteristics of immunogenic cancer cell death. Cell Death Differ 15:3-12.
89. Thorburn A and Debnath J (2011) Targeting chaperone-mediated autophagy in cancer. Sci Transl Med 3:109ps145.
90. Thorburn J, Horita H, Redzic J, Hansen K, Frankel AE, and Thorburn A (2009) Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ 16:175-183.
91. Torgersen ML, Engedal N, Bøe SO, Hokland P, and Simonsen A (2013) Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t (8;21) AML cells. Blood 122:2467-2476.
92. Villa-Morales M and Fernández-Piqueras J (2012) Targeting the Fas/FasL signaling pathway in cancer therapy. Expert Opin Ther Targets 16:85-101.
93. Walker T, Mitchell C, Park MA, Yacoub A, Graf M, Rahmani M, Houghton PJ, Voelkel-Johnson C, Grant S, and Dent P (2009) Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms. Mol Pharmacol 76:342-355.
94. Wang Y, Peng RQ, Li DD, Ding Y, Wu XQ, Zeng YX, Zhu XF, and Zhang XS (2011) Chloroquine enhances the cytotoxicity of topotecan by inhibiting autophagy in lung cancer cells. Chin J Can Cancer 30:690-700.
95. Wei Y, Zou Z, Becker N, and Erson M, Sumpter R, Xiao G, Kinch L, Koduru P, Christudass CS, and Veltri RW et al. (2013) EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell 154:1269-1284.
96. White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12:401-410.
97. Xie BS, Zhao HC, Yao SK, Zhuo DX, Jin B, Lv DC, Wu CL, Ma DL, Gao C, and Shu XM et al. (2011) Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells. Int J Mol Med 27:599-606.
98. Xu Y, Yu H, Qin H, Kang J, Yu C, Zhong J, Su J, Li H, and Sun L (2012) Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells. Cancer Lett 314:232-243.
99. Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, Bause A, Li Y, Stommel JM, and Dell'antonio G et al. (2011) Pancreatic cancers require autophagy for tumor growth. Genes Dev 25:717-729.
100. Yang Z and Klionsky DJ (2010a) Eaten alive: a history of macroautophagy. Nat Cell Biol 12:814-822.
101. Yang Z and Klionsky DJ (2010b) Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 22:124-131.
102. Yonekawa T and Thorburn A (2013) Autophagy and cell death. Essays Biochem 55:105-117.
103. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF, Tavarë S, Arakawa S, Shimizu S, and Watt FM et al. (2009) Autophagy mediates the mitotic senescence transition. Genes Dev 23:798-803.
104. Young MM, Takahashi Y, Khan O, Park S, Hori T, Yun J, Sharma AK, Amin S, Hu C-D, and Zhang J et al. (2012) Autophagosomal membrane serves as platform for intracellular death-inducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis. J Biol Chem 287:12455-12468.
105. Zitvogel L, Apetoh L, Ghiringhelli F, and Rë F, Tesniere A, and Kroemer G (2008) The anticancer immune response: indispensable for therapeutic success? J Clin Invest 118:1991-2001.